
Europe Artificial Intelligence (AI) in Drug Discovery Market - Industry Trends and Forecast to 2029
Description
Europe Artificial Intelligence (AI) in Drug Discovery Market - Industry Trends and Forecast to 2029
Europe Artificial Intelligence (AI) in drug discovery market is projected to register a substantial CAGR of 52.0% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2022 to 2029.
Market Segmentation
Europe Artificial Intelligence (AI) in Drug Discovery Market, By Application (Novel Drug Candidates, Drug Optimization and Repurposing Preclinical Testing and Approval, Drug Monitoring, Finding New Diseases Associated Targets and Pathways, Understanding Disease Mechanisms, Aggregating and Synthesizing Information, Formation & Qualification of Hypotheses, De Novo Drug Design, Finding Drug Targets of an Old Drug, and Others), Technology (Machine Learning, Deep Learning, Natural Language Processing, and Others), Drug Type (Small Molecule and Large Molecule), Offering (Software and Services.), Indication (Immuno-Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, and Others), End Use (Contract Research Organizations (CROs), Pharmaceutical & Biotechnology Companies, Research Centers and Academic Institutes, and Others), Country (Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, and Rest of Europe) Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of the Europe Artificial Intelligence (AI) in drug discovery market are:
• Rise in incidence of chronic diseases propels need for AI in drug discovery
• Strategic collaborations, partnerships and products launch
Market Players
The key market players operating in the Europe Artificial Intelligence (AI) in drug discovery market are listed below:
• NVIDIA Corporation
• IBM Corp.
• Atomwise Inc.
• Microsoft
• Envisagenics
• Owkin Inc.
• BERG LLC
• Schrödinger, Inc.
• XtalPi Inc.
• BIOAGE Inc.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Europe Artificial Intelligence (AI) in drug discovery market is projected to register a substantial CAGR of 52.0% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2022 to 2029.
Market Segmentation
Europe Artificial Intelligence (AI) in Drug Discovery Market, By Application (Novel Drug Candidates, Drug Optimization and Repurposing Preclinical Testing and Approval, Drug Monitoring, Finding New Diseases Associated Targets and Pathways, Understanding Disease Mechanisms, Aggregating and Synthesizing Information, Formation & Qualification of Hypotheses, De Novo Drug Design, Finding Drug Targets of an Old Drug, and Others), Technology (Machine Learning, Deep Learning, Natural Language Processing, and Others), Drug Type (Small Molecule and Large Molecule), Offering (Software and Services.), Indication (Immuno-Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, and Others), End Use (Contract Research Organizations (CROs), Pharmaceutical & Biotechnology Companies, Research Centers and Academic Institutes, and Others), Country (Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, and Rest of Europe) Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of the Europe Artificial Intelligence (AI) in drug discovery market are:
• Rise in incidence of chronic diseases propels need for AI in drug discovery
• Strategic collaborations, partnerships and products launch
Market Players
The key market players operating in the Europe Artificial Intelligence (AI) in drug discovery market are listed below:
• NVIDIA Corporation
• IBM Corp.
• Atomwise Inc.
• Microsoft
• Envisagenics
• Owkin Inc.
• BERG LLC
• Schrödinger, Inc.
• XtalPi Inc.
• BIOAGE Inc.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Table of Contents
207 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of Europe Artificial Intelligence (Ai) In Drug Discovery Market
- 1.4 Currency And Pricing
- 1.5 Limitations
- 1.6 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Dbmr Tripod Data Validation Model
- 2.5 Primary Interviews With Key Opinion Leaders
- 2.6 Multivariate Modelling
- 2.7 Market Application Coverage Grid
- 2.8 Source Lifeline Curve
- 2.9 Dbmr Market Position Grid
- 2.10 Vendor Share Analysis
- 2.11 Secondary Sources
- 2.12 Assumptions
- 3 Executive Summary
- 4 Premium Insight
- 4.1 Pestel Analysis
- 4.2 Poretsr’s Five Forces
- 5 Market Overview
- 5.1 Drivers
- 5.1.1 The Rise In Incidence Of Chronic Diseases Propels Need For Artificial Intelligence (Ai) In Drug Discovery
- 5.1.2 Strategic Collaborations, Partnerships, And Products Launch
- 5.1.3 Reduction In Total Time Involved In Drug Discovery Process
- 5.1.4 Advancement Of Artificial Intelligence In The Healthcare Industry
- 5.2 Restraints
- 5.2.1 High Cost Associated With Technology And Technical Limitations
- 5.2.2 Disadvantages And Risks Associated With Ai In Drug Discovery
- 5.2.3 Lack Of Available Quality Data
- 5.3 Opportunities
- 5.3.1 Rise In The Investments For R&D
- 5.3.2 Rising Healthcare Infrastructure
- 5.3.3 Development Of Novel Tools
- 5.4 Challenges
- 5.4.1 The Europe Shortage Of Ai Talent
- 5.4.2 Ethical, Legal, And Regulatory Issues For Ai Adoption In The Pharmaceutical Sciences
- 6 Europe Artificial Intelligence (Ai) In Drug Discovery Market, By Offering
- 6.1 Overview
- 6.2 Software
- 6.2.1 Integrated
- 6.2.2 Standalone
- 6.3 Services
- 7 Europe Artificial Intelligence (Ai) In Drug Discovery Market, By Technology
- 7.1 Overview
- 7.2 Machine Learning (Ml)
- 7.2.1 Supervised Learning
- 7.2.2 Unsupervised Learning
- 7.2.3 Reinforcement Learning
- 7.3 Deep Learning
- 7.4 Natural Language Processing (Nlp)
- 7.5 Others
- 8 Europe Artificial Intelligence (Ai) In Drug Discovery Market , By Drug Type
- 8.1 Overview
- 8.2 Small Molecule
- 8.3 Large Molecule
- 9 Europe Artificial Intelligence (Ai) In Drug Discovery Market, By Application
- 9.1 Overview
- 9.2 Novel Drug Candidates
- 9.2.1 Predict Bioactivity Of Small Molecule
- 9.2.2 Identify Biologics Target
- 9.2.3 Others
- 9.3 Drug Optimisation And Re-purposing Pre-clinical Testing And Approval
- 9.4 Drug Monitoring
- 9.5 Aggregating And Synthesizing Information
- 9.6 De Novo Drug Design
- 9.7 Finding Drug Targets Of An Old Drug
- 9.8 Formation & Qualification Of Hypotheses
- 9.9 Understanding Disease Mechanisms
- 9.10 Finding New Disease-associated Targets And Pathways
- 9.11 Others
- 10 Europe Artificial Intelligence (Ai) In Drug Discovery Market, By Indication
- 10.1 Overview
- 10.2 Immune-oncology
- 10.2.1 Breast Cancer
- 10.2.2 Lung Cancer
- 10.2.3 Colorectal Cancer
- 10.2.4 Prostate Cancer
- 10.2.5 Pancreatic Cancer
- 10.2.6 Brain Cancer
- 10.2.7 Leukemia
- 10.2.8 Others
- 10.3 Neurodegenerative Diseases
- 10.4 Cardiovascular Diseases
- 10.5 Metabolic Diseases
- 10.6 Others
- 11 Europe Artificial Intelligence (Ai) In Drug Discovery Market , By End Use
- 11.1 Overview
- 11.2 Contract Research Organizations
- 11.3 Pharmaceutical & Biotechnology Companies
- 11.4 Research Centers And Academic Institutes
- 11.5 Others
- 12 Europe Artificial Intelligence (Ai) In Drug Discovery Market, By Region
- 12.1 Europe
- 12.1.1 U.K.
- 12.1.2 France
- 12.1.3 Germany
- 12.1.4 Spain
- 12.1.5 Italy
- 12.1.6 Russia
- 12.1.7 Netherlands
- 12.1.8 Switzerland
- 12.1.9 Turkey
- 12.1.10 Belgium
- 12.1.11 Rest Of Europe
- 13 Europe Artificial Intelligence (Ai) In Drug Discovery Market: Company Landscape
- 13.1 Company Share Analysis: Europe
- 14 Swot Analysis
- 15 Company Profiles
- 15.1 Nvidia Corporation
- 15.1.1 Company Snapshot
- 15.1.2 Revenue Analysis
- 15.1.3 Company Share Analysis
- 15.1.4 Product Portfolio
- 15.1.5 Recent Developments
- 15.2 Microsoft
- 15.2.1 Company Snapshot
- 15.2.2 Revenue Analysis
- 15.2.3 Company Share Analysis
- 15.2.4 Product Portfolio
- 15.2.5 Recent Development
- 15.3 Ibm Corp
- 15.3.1 Company Snapshot
- 15.3.2 Revenue Analysis
- 15.3.3 Company Share Analysis
- 15.3.4 Product Portfolio
- 15.3.5 Recent Development
- 15.4 Schrödinger, Inc.
- 15.4.1 Company Snapshot
- 15.4.2 Revenue Analysis
- 15.4.3 Company Share Analysis
- 15.4.4 Product Portfolio
- 15.4.5 Recent Developments
- 15.5 Berg Llc
- 15.5.1 Company Snapshot
- 15.5.2 Company Share Analysis
- 15.5.3 Product Portfolio
- 15.5.4 Recent Developments
- 15.6 Ardigen
- 15.6.1 Company Snapshot
- 15.6.2 Product Portfolio
- 15.6.3 Recent Developments
- 15.7 Exscientia
- 15.7.1 Company Snapshot
- 15.7.2 Revenue Analysis
- 15.7.3 Product Portfolio
- 15.7.4 Recent Developments
- 15.8 Aria Pharmaceuticals, Inc.
- 15.8.1 Company Snapshot
- 15.8.2 Product Portfolio
- 15.8.3 Recent Developments
- 15.9 Atomwise Inc.
- 15.9.1 Company Snapshot
- 15.9.2 Product Portfolio
- 15.9.3 Recent Developments
- 15.10 Benevolent Ai
- 15.10.1 Company Snapshot
- 15.10.2 Revenue Analysis
- 15.10.3 Product Portfolio
- 15.10.4 Recent Developments
- 15.11 Bioage Inc.,
- 15.11.1 Company Snapshot
- 15.11.2 Product Portfolio
- 15.11.3 Recent Developments
- 15.12 Cloud
- 15.12.1 Company Snapshot
- 15.12.2 Product Portfolio
- 15.12.3 Recent Development
- 15.13 Cyclica
- 15.13.1 Company Snapshot
- 15.13.2 Product Portfolio
- 15.13.3 Recent Developments
- 15.14 Deep Genomics
- 15.14.1 Company Snapshot
- 15.14.2 Product Portfolio
- 15.14.3 Recent Developments
- 15.15 Envisagenics
- 15.15.1 Company Snapshot
- 15.15.2 Product Portfolio
- 15.15.3 Recent Developments
- 15.16 Insilico Medicine
- 15.16.1 Company Snapshot
- 15.16.2 Product Portfolio
- 15.16.3 Recent Developments
- 15.17 Numedii, Inc.
- 15.17.1 Company Snapshot
- 15.17.2 Product Portfolio
- 15.17.3 Recent Development
- 15.18 Owkin Inc.
- 15.18.1 Company Snapshot
- 15.18.2 Product Portfolio
- 15.18.3 Recent Development
- 15.19 Xtalpi Inc.
- 15.19.1 Company Snapshot
- 15.19.2 Product Portfolio
- 15.19.3 Recent Developments
- 16 Questionnaire
- 17 Related Reports 207
- List Of Tables
- Table 1 Europe Artificial Intelligence (Ai) In Drug Discovery Market, By Offering, 2020-2029 (Usd Million)
- Table 2 Europe Software In Artificial Intelligence (Ai) In Drug Discovery Market, By Region, 2020-2029 (Usd Million)
- Table 3 Europe Software In Artificial Intelligence (Ai) In Drug Discovery Market, By Type, 2020-2029 (Usd Million)
- Table 4 Europe Services In Artificial Intelligence (Ai) In Drug Discovery Market, By Region, 2020-2029 (Usd Million)
- Table 5 Europe Artificial Intelligence (Ai) In Drug Discovery Market, By Technology, 2020-2029 (Usd Million)
- Table 6 Europe Machine Learning (Ml) In Artificial Intelligence (Ai) In Drug Discovery Market, By Region, 2020-2029 (Usd Million)
- Table 7 Europe Machine Learning (Ml) In Artificial Intelligence (Ai) In Drug Discovery Market, By Technology, 2020-2029 (Usd Million)
- Table 8 Europe Deep Learning In Artificial Intelligence (Ai) In Drug Discovery Market, By Region, 2020-2029 (Usd Million)
- Table 9 Europe Natural Language Processing (Nlp) In Artificial Intelligence (Ai) In Drug Discovery Market, By Region, 2020-2029 (Usd Million)
- Table 10 Europe Others In Artificial Intelligence (Ai) In Drug Discovery Market, By Region, 2020-2029 (Usd Million)
- Table 11 Europe Artificial Intelligence (Ai) In Drug Discovery Market, By Drug Type, 2020-2029 (Usd Million)
- Table 12 Europe Small Molecule In Artificial Intelligence (Ai) In Drug Discovery Market, By Region, 2020-2029 (Usd Million)
- Table 13 Europe Large Molecule In Artificial Intelligence (Ai) In Drug Discovery Market, By Region, 2020-2029 (Usd Million)
- Table 14 Europe Artificial Intelligence (Ai) In Drug Discovery Market, By Application, 2020-2029 (Usd Million)
- Table 15 Europe Novel Drug Candidates In Artificial Intelligence (Ai) In Drug Discovery Market, By Region, 2020-2029 (Usd Million)
- Table 16 Europe Novel Drug Candidates In Artificial Intelligence (Ai) In Drug Discovery Market, By Application, 2020-2029 (Usd Million)
- Table 17 Europe Drug Optimisation And Re-purposing Pre-clinical Testing And Approval In Artificial Intelligence (Ai) In Drug Discovery Market, By Region, 2020-2029 (Usd Million)
- Table 18 Europe Drug Monitoring In Artificial Intelligence (Ai) In Drug Discovery Market, By Region, 2020-2029 (Usd Million)
- Table 19 Europe Aggregating And Synthesizing Information In Artificial Intelligence (Ai) In Drug Discovery Market, By Region, 2020-2029 (Usd Million)
- Table 20 Europe De Novo Drug Design In Artificial Intelligence (Ai) In Drug Discovery Market, By Region, 2020-2029 (Usd Million)
- Table 21 Europe Finding Drug Targets Of An Old Drug In Artificial Intelligence (Ai) In Drug Discovery Market, By Region, 2020-2029 (Usd Million)
- Table 22 Europe Formation & Qualification Of Hypotheses In Artificial Intelligence (Ai) In Drug Discovery Market, By Region, 2020-2029 (Usd Million)
- Table 23 Europe Understanding Disease Mechanisms In Artificial Intelligence (Ai) In Drug Discovery Market, By Region, 2020-2029 (Usd Million)
- Table 24 Europe Finding New Disease-associated Targets And Pathways In Artificial Intelligence (Ai) In Drug Discovery Market, By Region, 2020-2029 (Usd Million)
- Table 25 Europe Others In Artificial Intelligence (Ai) In Drug Discovery Market, By Region, 2020-2029 (Usd Million)
- Table 26 Europe Artificial Intelligence (Ai) In Drug Discovery Market, By Indication, 2020-2029 (Usd Million)
- Table 27 Europe Immuno-oncology In Artificial Intelligence (Ai) In Drug Discovery Market, By Region, 2020-2029 (Usd Million)
- Table 28 Europe Immuno-oncology In Artificial Intelligence (Ai) In Drug Discovery Market, By Indication, 2020-2029 (Usd Million)
- Table 29 Europe Neurodegenerative Diseases In Artificial Intelligence (Ai) In Drug Discovery Market, By Region, 2020-2029 (Usd Million)
- Table 30 Europe Cardiovascular Diseases In Artificial Intelligence (Ai) In Drug Discovery Market, By Region, 2020-2029 (Usd Million)
- Table 31 Europe Metabolic Diseases In Artificial Intelligence (Ai) In Drug Discovery Market, By Region, 2020-2029 (Usd Million)
- Table 32 Europe Others In Artificial Intelligence (Ai) In Drug Discovery Market, By Region, 2020-2029 (Usd Million)
- Table 33 Glob Europe Artificial Intelligence (Ai) In Drug Discovery Market, By End Use, 2020-2029 (Usd Million)
- Table 34 Europe Contract Research Organizations In Artificial Intelligence (Ai) In Drug Discovery Market, By Region, 2020-2029 (Usd Million)
- Table 35 Europe Pharmaceutical & Biotechnology Companies In Artificial Intelligence (Ai) In Drug Discovery Market, By Region, 2020-2029 (Usd Million)
- Table 36 Europe Research Centres And Academic Institutes In Artificial Intelligence (Ai) In Drug Discovery Market, By Region, 2020-2029 (Usd Million)
- Table 37 Europe Others In Artificial Intelligence (Ai) In Drug Discovery Market, By Region, 2020-2029 (Usd Million)
- Table 38 Europe Artificial Intelligence (Ai) In Drug Discovery Market, By Country, 2020-2029 (Usd Million)
- Table 39 Europe Artificial Intelligence (Ai) In Drug Discovery Market, By Offering, 2020-2029 (Usd Million)
- Table 40 Europe Software In Artificial Intelligence (Ai) In Drug Discovery Market, By Type, 2020-2029 (Usd Million)
- Table 41 Europe Artificial Intelligence (Ai) In Drug Discovery Market, By Technology, 2020-2029 (Usd Million)
- Table 42 Europe Machine Learning (Ml) In Artificial Intelligence (Ai) In Drug Discovery Market, By Technology, 2020-2029 (Usd Million)
- Table 43 Europe Artificial Intelligence (Ai) In Drug Discovery Market, By Drug Type, 2020-2029 (Usd Million)
- Table 44 Europe Artificial Intelligence (Ai) In Drug Discovery Market, By Application, 2020-2029 (Usd Million)
- Table 45 Europe Novel Drug Candidates In Artificial Intelligence (Ai) In Drug Discovery Market, By Application, 2020-2029 (Usd Million)
- Table 46 Europe Artificial Intelligence (Ai) In Drug Discovery Market, By Indication, 2020-2029 (Usd Million)
- Table 47 Europe Immuno-oncology In Artificial Intelligence (Ai) In Drug Discovery Market, By Indication, 2020-2029 (Usd Million)
- Table 48 Europe Artificial Intelligence (Ai) In Drug Discovery Market, By End Use, 2020-2029 (Usd Million)
- Table 49 U.K. Artificial Intelligence (Ai) In Drug Discovery Market, By Offering, 2020-2029 (Usd Million)
- Table 50 U.K. Software In Artificial Intelligence (Ai) In Drug Discovery Market, By Type, 2020-2029 (Usd Million)
- Table 51 U.K. Artificial Intelligence (Ai) In Drug Discovery Market, By Technology, 2020-2029 (Usd Million)
- Table 52 U.K. Machine Learning (Ml) In Artificial Intelligence (Ai) In Drug Discovery Market, By Technology, 2020-2029 (Usd Million)
- Table 53 U.K. Artificial Intelligence (Ai) In Drug Discovery Market, By Drug Type, 2020-2029 (Usd Million)
- Table 54 U.K. Artificial Intelligence (Ai) In Drug Discovery Market, By Application, 2020-2029 (Usd Million)
- Table 55 U.K. Novel Drug Candidates In Artificial Intelligence (Ai) In Drug Discovery Market, By Application, 2020-2029 (Usd Million)
- Table 56 U.K. Artificial Intelligence (Ai) In Drug Discovery Market, By Indication, 2020-2029 (Usd Million)
- Table 57 U.K. Immuno-oncology In Artificial Intelligence (Ai) In Drug Discovery Market, By Indication, 2020-2029 (Usd Million)
- Table 58 U.K. Artificial Intelligence (Ai) In Drug Discovery Market, By End Use, 2020-2029 (Usd Million)
- Table 59 France Artificial Intelligence (Ai) In Drug Discovery Market, By Offering, 2020-2029 (Usd Million)
- Table 60 France Software In Artificial Intelligence (Ai) In Drug Discovery Market, By Type, 2020-2029 (Usd Million)
- Table 61 France Artificial Intelligence (Ai) In Drug Discovery Market, By Technology, 2020-2029 (Usd Million)
- Table 62 France Machine Learning (Ml) In Artificial Intelligence (Ai) In Drug Discovery Market, By Technology, 2020-2029 (Usd Million)
- Table 63 France Artificial Intelligence (Ai) In Drug Discovery Market, By Drug Type, 2020-2029 (Usd Million)
- Table 64 France Artificial Intelligence (Ai) In Drug Discovery Market, By Application, 2020-2029 (Usd Million)
- Table 65 France Novel Drug Candidates In Artificial Intelligence (Ai) In Drug Discovery Market, By Application, 2020-2029 (Usd Million)
- Table 66 France Artificial Intelligence (Ai) In Drug Discovery Market, By Indication, 2020-2029 (Usd Million)
- Table 67 France Immuno-oncology In Artificial Intelligence (Ai) In Drug Discovery Market, By Indication, 2020-2029 (Usd Million)
- Table 68 France Artificial Intelligence (Ai) In Drug Discovery Market, By End Use, 2020-2029 (Usd Million)
- Table 69 Germany Artificial Intelligence (Ai) In Drug Discovery Market, By Offering, 2020-2029 (Usd Million)
- Table 70 Germany Software In Artificial Intelligence (Ai) In Drug Discovery Market, By Type, 2020-2029 (Usd Million)
- Table 71 Germany Artificial Intelligence (Ai) In Drug Discovery Market, By Technology, 2020-2029 (Usd Million)
- Table 72 Germany Machine Learning (Ml) In Artificial Intelligence (Ai) In Drug Discovery Market, By Technology, 2020-2029 (Usd Million)
- Table 73 Germany Artificial Intelligence (Ai) In Drug Discovery Market, By Drug Type, 2020-2029 (Usd Million)
- Table 74 Germany Artificial Intelligence (Ai) In Drug Discovery Market, By Application, 2020-2029 (Usd Million)
- Table 75 Germany Novel Drug Candidates In Artificial Intelligence (Ai) In Drug Discovery Market, By Application, 2020-2029 (Usd Million)
- Table 76 Germany Artificial Intelligence (Ai) In Drug Discovery Market, By Indication, 2020-2029 (Usd Million)
- Table 77 Germany Immuno-oncology In Artificial Intelligence (Ai) In Drug Discovery Market, By Indication, 2020-2029 (Usd Million)
- Table 78 Germany Artificial Intelligence (Ai) In Drug Discovery Market, By End Use, 2020-2029 (Usd Million)
- Table 79 Spain Artificial Intelligence (Ai) In Drug Discovery Market, By Offering, 2020-2029 (Usd Million)
- Table 80 Spain Software In Artificial Intelligence (Ai) In Drug Discovery Market, By Type, 2020-2029 (Usd Million)
- Table 81 Spain Artificial Intelligence (Ai) In Drug Discovery Market, By Technology, 2020-2029 (Usd Million)
- Table 82 Spain Machine Learning (Ml) In Artificial Intelligence (Ai) In Drug Discovery Market, By Technology, 2020-2029 (Usd Million)
- Table 83 Spain Artificial Intelligence (Ai) In Drug Discovery Market, By Drug Type, 2020-2029 (Usd Million)
- Table 84 Spain Artificial Intelligence (Ai) In Drug Discovery Market, By Application, 2020-2029 (Usd Million)
- Table 85 Spain Novel Drug Candidates In Artificial Intelligence (Ai) In Drug Discovery Market, By Application, 2020-2029 (Usd Million)
- Table 86 Spain Artificial Intelligence (Ai) In Drug Discovery Market, By Indication, 2020-2029 (Usd Million)
- Table 87 Spain Immuno-oncology In Artificial Intelligence (Ai) In Drug Discovery Market, By Indication, 2020-2029 (Usd Million)
- Table 88 Spain Artificial Intelligence (Ai) In Drug Discovery Market, By End Use, 2020-2029 (Usd Million)
- Table 89 Italy Artificial Intelligence (Ai) In Drug Discovery Market, By Offering, 2020-2029 (Usd Million)
- Table 90 Italy Software In Artificial Intelligence (Ai) In Drug Discovery Market, By Type, 2020-2029 (Usd Million)
- Table 91 Italy Artificial Intelligence (Ai) In Drug Discovery Market, By Technology, 2020-2029 (Usd Million)
- Table 92 Italy Machine Learning (Ml) In Artificial Intelligence (Ai) In Drug Discovery Market, By Technology, 2020-2029 (Usd Million)
- Table 93 Italy Artificial Intelligence (Ai) In Drug Discovery Market, By Drug Type, 2020-2029 (Usd Million)
- Table 94 Italy Artificial Intelligence (Ai) In Drug Discovery Market, By Application, 2020-2029 (Usd Million)
- Table 95 Italy Novel Drug Candidates In Artificial Intelligence (Ai) In Drug Discovery Market, By Application, 2020-2029 (Usd Million)
- Table 96 Italy Artificial Intelligence (Ai) In Drug Discovery Market, By Indication, 2020-2029 (Usd Million)
- Table 97 Italy Immuno-oncology In Artificial Intelligence (Ai) In Drug Discovery Market, By Indication, 2020-2029 (Usd Million)
- Table 98 Italy Artificial Intelligence (Ai) In Drug Discovery Market, By End Use, 2020-2029 (Usd Million)
- Table 99 Russia Artificial Intelligence (Ai) In Drug Discovery Market, By Offering, 2020-2029 (Usd Million)
- Table 100 Russia Software In Artificial Intelligence (Ai) In Drug Discovery Market, By Type, 2020-2029 (Usd Million)
- Table 101 Russia Artificial Intelligence (Ai) In Drug Discovery Market, By Technology, 2020-2029 (Usd Million)
- Table 102 Russia Machine Learning (Ml) In Artificial Intelligence (Ai) In Drug Discovery Market, By Technology, 2020-2029 (Usd Million)
- Table 103 Russia Artificial Intelligence (Ai) In Drug Discovery Market, By Drug Type, 2020-2029 (Usd Million)
- Table 104 Russia Artificial Intelligence (Ai) In Drug Discovery Market, By Application, 2020-2029 (Usd Million)
- Table 105 Russia Novel Drug Candidates In Artificial Intelligence (Ai) In Drug Discovery Market, By Application, 2020-2029 (Usd Million)
- Table 106 Russia Artificial Intelligence (Ai) In Drug Discovery Market, By Indication, 2020-2029 (Usd Million)
- Table 107 Russia Immuno-oncology In Artificial Intelligence (Ai) In Drug Discovery Market, By Indication, 2020-2029 (Usd Million)
- Table 108 Russia Artificial Intelligence (Ai) In Drug Discovery Market, By End Use, 2020-2029 (Usd Million)
- Table 109 Netherlands Artificial Intelligence (Ai) In Drug Discovery Market, By Offering, 2020-2029 (Usd Million)
- Table 110 Netherlands Software In Artificial Intelligence (Ai) In Drug Discovery Market, By Type, 2020-2029 (Usd Million)
- Table 111 Netherlands Artificial Intelligence (Ai) In Drug Discovery Market, By Technology, 2020-2029 (Usd Million)
- Table 112 Netherlands Machine Learning (Ml) In Artificial Intelligence (Ai) In Drug Discovery Market, By Technology, 2020-2029 (Usd Million)
- Table 113 Netherlands Artificial Intelligence (Ai) In Drug Discovery Market, By Drug Type, 2020-2029 (Usd Million)
- Table 114 Netherlands Artificial Intelligence (Ai) In Drug Discovery Market, By Application, 2020-2029 (Usd Million)
- Table 115 Netherlands Novel Drug Candidates In Artificial Intelligence (Ai) In Drug Discovery Market, By Application, 2020-2029 (Usd Million)
- Table 116 Netherlands Artificial Intelligence (Ai) In Drug Discovery Market, By Indication, 2020-2029 (Usd Million)
- Table 117 Netherlands Immuno-oncology In Artificial Intelligence (Ai) In Drug Discovery Market, By Indication, 2020-2029 (Usd Million)
- Table 118 Netherlands Artificial Intelligence (Ai) In Drug Discovery Market, By End Use, 2020-2029 (Usd Million)
- Table 119 Switzerland Artificial Intelligence (Ai) In Drug Discovery Market, By Offering, 2020-2029 (Usd Million)
- Table 120 Switzerland Software In Artificial Intelligence (Ai) In Drug Discovery Market, By Type, 2020-2029 (Usd Million)
- Table 121 Switzerland Artificial Intelligence (Ai) In Drug Discovery Market, By Technology, 2020-2029 (Usd Million)
- Table 122 Switzerland Machine Learning (Ml) In Artificial Intelligence (Ai) In Drug Discovery Market, By Technology, 2020-2029 (Usd Million)
- Table 123 Switzerland Artificial Intelligence (Ai) In Drug Discovery Market, By Drug Type, 2020-2029 (Usd Million)
- Table 124 Switzerland Artificial Intelligence (Ai) In Drug Discovery Market, By Application, 2020-2029 (Usd Million)
- Table 125 Switzerland Novel Drug Candidates In Artificial Intelligence (Ai) In Drug Discovery Market, By Application, 2020-2029 (Usd Million)
- Table 126 Switzerland Artificial Intelligence (Ai) In Drug Discovery Market, By Indication, 2020-2029 (Usd Million)
- Table 127 Switzerland Immuno-oncology In Artificial Intelligence (Ai) In Drug Discovery Market, By Indication, 2020-2029 (Usd Million)
- Table 128 Switzerland Artificial Intelligence (Ai) In Drug Discovery Market, By End Use, 2020-2029 (Usd Million)
- Table 129 Turkey Artificial Intelligence (Ai) In Drug Discovery Market, By Offering, 2020-2029 (Usd Million)
- Table 130 Turkey Software In Artificial Intelligence (Ai) In Drug Discovery Market, By Type, 2020-2029 (Usd Million)
- Table 131 Turkey Artificial Intelligence (Ai) In Drug Discovery Market, By Technology, 2020-2029 (Usd Million)
- Table 132 Turkey Machine Learning (Ml) In Artificial Intelligence (Ai) In Drug Discovery Market, By Technology, 2020-2029 (Usd Million)
- Table 133 Turkey Artificial Intelligence (Ai) In Drug Discovery Market, By Drug Type, 2020-2029 (Usd Million)
- Table 134 Turkey Artificial Intelligence (Ai) In Drug Discovery Market, By Application, 2020-2029 (Usd Million)
- Table 135 Turkey Novel Drug Candidates In Artificial Intelligence (Ai) In Drug Discovery Market, By Application, 2020-2029 (Usd Million)
- Table 136 Turkey Artificial Intelligence (Ai) In Drug Discovery Market, By Indication, 2020-2029 (Usd Million)
- Table 137 Turkey Immuno-oncology In Artificial Intelligence (Ai) In Drug Discovery Market, By Indication, 2020-2029 (Usd Million)
- Table 138 Turkey Artificial Intelligence (Ai) In Drug Discovery Market, By End Use, 2020-2029 (Usd Million)
- Table 139 Belgium Artificial Intelligence (Ai) In Drug Discovery Market, By Offering, 2020-2029 (Usd Million)
- Table 140 Belgium Software In Artificial Intelligence (Ai) In Drug Discovery Market, By Type, 2020-2029 (Usd Million)
- Table 141 Belgium Artificial Intelligence (Ai) In Drug Discovery Market, By Technology, 2020-2029 (Usd Million)
- Table 142 Belgium Machine Learning (Ml) In Artificial Intelligence (Ai) In Drug Discovery Market, By Technology, 2020-2029 (Usd Million)
- Table 143 Belgium Artificial Intelligence (Ai) In Drug Discovery Market, By Drug Type, 2020-2029 (Usd Million)
- Table 144 Belgium Artificial Intelligence (Ai) In Drug Discovery Market, By Application, 2020-2029 (Usd Million)
- Table 145 Belgium Novel Drug Candidates In Artificial Intelligence (Ai) In Drug Discovery Market, By Application, 2020-2029 (Usd Million)
- Table 146 Belgium Artificial Intelligence (Ai) In Drug Discovery Market, By Indication, 2020-2029 (Usd Million)
- Table 147 Belgium Immuno-oncology In Artificial Intelligence (Ai) In Drug Discovery Market, By Indication, 2020-2029 (Usd Million)
- Table 148 Belgium Artificial Intelligence (Ai) In Drug Discovery Market, By End Use, 2020-2029 (Usd Million)
- Table 149 Rest Of Europe Artificial Intelligence (Ai) In Drug Discovery Market, By Offering, 2020-2029 (Usd Million) 155
- List Of Figures
- Figure 1 Europe Artificial Intelligence (Ai) In Drug Discovery Market: Segmentation
- Figure 2 Europe Artificial Intelligence (Ai) In Drug Discovery Market: Data Triangulation
- Figure 3 Europe Artificial Intelligence (Ai) In Drug Discovery Market: Droc Analysis
- Figure 4 Europe Artificial Intelligence (Ai) In Drug Discovery Market: Europe Vs Regional Market Analysis
- Figure 5 Europe Artificial Intelligence (Ai) In Drug Discovery Market: Company Research Analysis
- Figure 6 Europe Artificial Intelligence (Ai) In Drug Discovery Market: Interview Demographics
- Figure 7 Europe Artificial Intelligence (Ai) In Drug Discovery Market: Market Application Coverage Grid
- Figure 8 Europe Artificial Intelligence (Ai) In Drug Discovery Market: Dbmr Market Position Grid
- Figure 9 Europe Artificial Intelligence (Ai) In Drug Discovery Market: Vendor Share Analysis
- Figure 10 Europe Artificial Intelligence (Ai) In Drug Discovery Market: Segmentation
- Figure 11 The Growing Need To Curb Drug Discovery Costs And Reduce Time Involved In The Drug Development Process, The Rising Adoption Of Cloud-based Applications And Services, And The Impending Patent Expiry Of Blockbuster Drugs Are Expected To Drive The Growth Of The Europe Artificial Intelligence (Ai) In Drug Discovery Market In The Forecast Period Of 2022 To 2029
- Figure 12 Software Is Expected To Account For The Largest Share Of The Europe Artificial Intelligence (Ai) In Drug Discovery Market In 2022 And 2029
- Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The Europe Artificial Intelligence (Ai) In Drug Discovery Market
- Figure 14 Europe Artificial Intelligence (Ai) In Drug Discovery Market: By Offering, 2021
- Figure 15 Europe Artificial Intelligence (Ai) In Drug Discovery Market: By Offering, 2022-2029 (Usd Million)
- Figure 16 Europe Artificial Intelligence (Ai) In Drug Discovery Market: By Offering, Cagr (2022-2029)
- Figure 17 Europe Artificial Intelligence (Ai) In Drug Discovery Market: By Offering, Lifeline Curve
- Figure 18 Europe Artificial Intelligence (Ai) In Drug Discovery Market: By Technology, 2021
- Figure 19 Europe Artificial Intelligence (Ai) In Drug Discovery Market: By Technology, 2022-2029 (Usd Million)
- Figure 20 Europe Artificial Intelligence (Ai) In Drug Discovery Market: By Technology, Cagr (2022-2029)
- Figure 21 Europe Artificial Intelligence (Ai) In Drug Discovery Market: By Technology, Lifeline Curve
- Figure 22 Europe Artificial Intelligence (Ai) In Drug Discovery Market : By Drug Type, 2021
- Figure 23 Europe Artificial Intelligence (Ai) In Drug Discovery Market : By Drug Type, 2022-2029 (Usd Million)
- Figure 24 Europe Artificial Intelligence (Ai) In Drug Discovery Market : By Drug Type, Cagr (2022-2029)
- Figure 25 Europe Artificial Intelligence (Ai) In Drug Discovery Market : By Drug Type, Lifeline Curve
- Figure 26 Europe Artificial Intelligence (Ai) In Drug Discovery Market: By Application, 2021
- Figure 27 Europe Artificial Intelligence (Ai) In Drug Discovery Market: By Application, 2020-2029 (Usd Million)
- Figure 28 Europe Artificial Intelligence (Ai) In Drug Discovery Market: By Application, Cagr (2022-2029)
- Figure 29 Europe Artificial Intelligence (Ai) In Drug Discovery Market: By Application, Lifeline Curve
- Figure 30 Europe Artificial Intelligence (Ai) In Drug Discovery Market: By Indication, 2021
- Figure 31 Europe Artificial Intelligence (Ai) In Drug Discovery Market: By Indication, 2020-2029 (Usd Million)
- Figure 32 Europe Artificial Intelligence (Ai) In Drug Discovery Market: By Indication, Cagr (2022-2029)
- Figure 33 Europe Artificial Intelligence (Ai) In Drug Discovery Market: By Indication, Lifeline Curve
- Figure 34 Europe Artificial Intelligence (Ai) In Drug Discovery Market: By End Use, 2021
- Figure 35 Europe Artificial Intelligence (Ai) In Drug Discovery Market: By End Use, 2022-2029 (Usd Million)
- Figure 36 Europe Artificial Intelligence (Ai) In Drug Discovery Market : By End Use, Cagr (2022-2029)
- Figure 37 Europe Artificial Intelligence (Ai) In Drug Discovery Market : By End Use, Lifeline Curve
- Figure 38 Europe Artificial Intelligence (Ai) In Drug Discovery Market: Snapshot (2021)
- Figure 39 Europe Artificial Intelligence (Ai) In Drug Discovery Market: By Country (2021)
- Figure 40 Europe Artificial Intelligence (Ai) In Drug Discovery Market: By Country (2022 & 2029)
- Figure 41 Europe Artificial Intelligence (Ai) In Drug Discovery Market: By Country (2021 & 2029)
- Figure 42 Europe Artificial Intelligence (Ai) In Drug Discovery Market: By Offering (2022-2029)
- Figure 43 Europe Artificial Intelligence (Ai) In Drug Discovery Market: Company Share 2021 (%) 155
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.